Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
World J Urol ; 37(7): 1369-1375, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30288598

RESUMEN

PURPOSE: Aquablation of the prostate using the AquaBeam™ system promises equivalent functional outcomes, reduced learning curve, and improved sexual function compared to transurethral prostate resection as shown in prospective randomized trials. This prospective cohort study aims to evaluate if published results can be transferred into the clinical routine in a non-selected patient collective. METHODS: This study includes all patients treated between September 2017 and June 2018 with Aquablation of the prostate. Patients have been evaluated prospectively for the perioperative course and early follow-up. Besides voiding parameter and symptom score, TRUS-volume change, ejaculatory function, and adverse events have been recorded. RESULTS: 118 consecutive patients have been treated in the given time. Aquablation could be carried out successfully in all patients. IPSS, QoL, Qmax, and PVR improved significantly after the procedure and continued to improve during 3-month follow-up. Mean OR time was 20 min, TRUS volume decreased by 65%, and 73% of the patients retained antegrade ejaculation. Thirteen adverse events (> Clavien-Dindo I) occurred in 10 patients. CONCLUSION: The surgical ablation of the prostate using Aquablation achieved significant and immediate improvement of functional voiding parameters Qmax and PVR as well as symptomatic improvement of IPSS and QoL. Aquablation seems to be safe and effective with a low perioperative complication profile even in a non-selected group of patients.


Asunto(s)
Técnicas de Ablación/métodos , Hiperplasia Prostática/cirugía , Resección Transuretral de la Próstata/métodos , Obstrucción Uretral/cirugía , Agua , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Hiperplasia Prostática/complicaciones , Disfunciones Sexuales Fisiológicas/epidemiología , Resultado del Tratamiento , Obstrucción Uretral/etiología
2.
World J Urol ; 31(6): 1427-32, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23358791

RESUMEN

PURPOSE: To describe the incidence and drug susceptibility profiles of uropathogenic extended-spectrum-ß-lactamase-producing Escherichia coli (ESBL-EC) during a 10-year period and to identify differences in resistance patterns between urological and non-urological ESBL-EC isolates. METHODS: Retrospective analysis of 191,564 urine samples obtained during 2001 to 2010 at the University Hospital Basel, Switzerland. The computerized database of the Clinical Microbiology Laboratory and the Division of Infectious Diseases and Hospital Epidemiology was used to identify ESBL-EC positive urine samples. ESBL-EC isolates were stratified according their origin into two groups: Urology and non-Urology isolates. RESULTS: The rate of ESBL-EC positive urine samples increased significantly during the study period (3 in 2001 compared to 55 in 2010, p < 0.05). The most active agents were imipenem, meropenem, and fosfomycin (100%), followed by amikacin (99.1%) and nitrofurantoin (84%). The least active substances were ampicillin-clavulanate (20%), sulfamethoxazole (28%), and ciprofloxacin (29.6%). ESBL-EC isolates from urological and non-urological patients showed similar susceptibility profiles. However, ESBL-EC isolates from urological patients were significantly less susceptible to ciprofloxacin compared to non-urological isolates (14.7 vs. 32.7%, p < 0.05). CONCLUSIONS: The rate of urinary ESBL-EC isolates is increasing. Their susceptibility to nitrofurantoin, fosfomycin, and carbapenems is excellent, whereas ampicillin-clavulanate, sulfamethoxazole, and ciprofloxacin demonstrate only low susceptibility. In particular, the use of ciprofloxacin should be strictly avoided in urologic patients with suspicion for an ESBL-EC urinary tract infection as well as routine antibiotic prophylaxis prior to urological interventions if not explicit indicated by current international guidelines or local resistance patterns.


Asunto(s)
Ciprofloxacina/uso terapéutico , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/epidemiología , Escherichia coli/aislamiento & purificación , Infecciones Urinarias/epidemiología , Sistema Urinario/microbiología , beta-Lactamasas/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Carbapenémicos/farmacología , Carbapenémicos/uso terapéutico , Ciprofloxacina/farmacología , Contraindicaciones , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Infecciones por Escherichia coli/tratamiento farmacológico , Femenino , Fosfomicina/farmacología , Fosfomicina/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Nitrofurantoína/farmacología , Nitrofurantoína/uso terapéutico , Prevalencia , Estudios Retrospectivos , Insuficiencia del Tratamiento , Resultado del Tratamiento , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Adulto Joven
3.
Urologe A ; 46(9): 1242-7, 2007 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-17665162

RESUMEN

INTRODUCTION AND OBJECTIVES: Laser therapy of symptomatic benign prostatic hyperplasia (BPH) remains a challenge for most urologic surgeons. The main goal of laser surgery is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity. Laser therapy encompasses a variety of techniques using different laser wavelengths, application systems, and surgical techniques to achieve contrasting tissue effects. In an in vitro animal model we compared the vaporization and coagulation effects of the potassium-titanyl-phosphate (KTP) laser, holmium:yttrium-aluminum-garnet (Ho:YAG) laser, and diode laser (980 nm). MATERIAL AND METHODS: In an in vitro model using isolated perfused porcine kidneys we investigated the vaporization, the coagulation effect, and the bleeding rate of the KTP, Ho:YAG, and diode lasers on five porcine kidneys each. The application of each laser type was standardized. The area of laser application was 1 cm x 1 cm. The KTP group received an application with 80 W, the Ho:YAG group an application with 10-30 W, and the diode group an application with 30, 60, and 100 W. Hemostasis was measured semiquantitatively. Ablation and coagulation were investigated macro- and microscopically. RESULTS: Concerning the ablation capacity, the diode laser is most effective (more than fivefold) compared to the KTP and Ho:YAG lasers but demonstrated a rather large coagulation zone of up to tenfold in comparison to the KTP and Ho:YAG lasers. Semiquantitatively, in terms of bleeding rate, all lasers were equivalent in this ex vivo model. CONCLUSIONS: Our very early and limited experience indicates that KTP (80 W) and Ho:YAG (30 W) laser application are equivalent in terms of tissue ablation capacity and coagulation in an experimental setting. The diode laser at 980 nm is superior in terms of ablation capacity but has a large coagulation zone. Concerning the bleeding rate all tested lasers are equivalent in this ex vivo model.


Asunto(s)
Riñón/cirugía , Coagulación con Láser/instrumentación , Terapia por Láser/instrumentación , Láseres de Estado Sólido/uso terapéutico , Animales , Diseño de Equipo , Humanos , Técnicas In Vitro , Riñón/patología , Masculino , Hiperplasia Prostática/cirugía , Porcinos , Resección Transuretral de la Próstata/instrumentación
5.
Urologe A ; 45(6): 769-80; quiz 781-2, 2006 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-16788796

RESUMEN

Today, the surgical treatment of the benign prostatic syndrome (BPS) often follows a course of drug treatment. Besides conventional transurethral resection of the prostate (TURP), which has represented the standard therapeutic option for decades, and its in part significant modifications ("vaporizing resection"; bipolar resection), much of the interest has shifted to alternative instrumental procedures like transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA) or several laser techniques. By reviewing the current literature, preferably from randomized controlled trials, these different procedures are critically assessed. Moreover, the present role of open prostatectomy is discussed.


Asunto(s)
Complicaciones Posoperatorias/etiología , Hiperplasia Prostática/cirugía , Resección Transuretral de la Próstata/instrumentación , Endoscopía , Diseño de Equipo , Disfunción Eréctil/etiología , Humanos , Masculino , Hemorragia Posoperatoria/etiología , Guías de Práctica Clínica como Asunto , Próstata/patología , Hiperplasia Prostática/patología , Ensayos Clínicos Controlados Aleatorios como Asunto , Retención Urinaria/etiología , Urodinámica/fisiología
6.
Nat Biotechnol ; 19(3): 268-72, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11231562

RESUMEN

Potato is a globally important crop. Unfortunately, potato farming is plagued with problems associated with the sprouting behavior of seed tubers. The data presented here demonstrate that using transgenic technology can influence this behavior. Transgenic tubers cytosolically expressing an inorganic pyrophosphatase gene derived from Escherichia coli under the control of the tuber-specific patatin promoter display significantly accelerated sprouting. The period of presprouting dormancy for transgenic tubers planted immediately after harvest is reduced by six to seven weeks when compared to wild-type tubers. This study demonstrates a method with which to regulate dormancy, an important aspect of potato crop management.


Asunto(s)
Escherichia coli/enzimología , Raíces de Plantas/crecimiento & desarrollo , Raíces de Plantas/genética , Pirofosfatasas/metabolismo , Solanum tuberosum/crecimiento & desarrollo , Solanum tuberosum/genética , Transgenes/genética , Metabolismo de los Hidratos de Carbono , Frío , Difosfatos/metabolismo , Escherichia coli/genética , Expresión Génica , Raíces de Plantas/enzimología , Raíces de Plantas/metabolismo , Plantas Modificadas Genéticamente , Pirofosfatasas/genética , Solanum tuberosum/enzimología , Solanum tuberosum/metabolismo , Almidón/biosíntesis , Factores de Tiempo , Transformación Genética
7.
FEBS Lett ; 431(3): 433-6, 1998 Jul 24.
Artículo en Inglés | MEDLINE | ID: mdl-9714558

RESUMEN

Recently, we found a 13-lipoxygenase in germinating cucumber cotyledons, which was located at the lipid body membrane. Based on its products formed mobilization of storage lipids seems to be initiated by this 13-lipoxygenase. For biochemical characterization its cDNA was expressed as His-tagged protein. Active recombinant enzyme was obtained from low temperature cultivation of E. coli after affinity purification. It (i) exhibited an unchanged region specificity, and (ii) showed a pH optimum of 7.2 against trilinolein as substrate. We compared its ability to oxygenate trilinolein with the one of another 13-lipoxygenase, soybean lipoxygenase-1. At the pH optimum of soybean lipoxygenase-1 (9.0), trilinolein was oxygenated only to 28% of the amount converted by the lipid body lipoxygenase. Moreover, trilinolein oxygenation by soybean lipoxygenase-1 leads mainly to monohydroperoxy derivatives, whereas oxygenation by lipid body LOX leads to a trihydroperoxy derivative.


Asunto(s)
Histidina/química , Lipooxigenasa/metabolismo , Oxígeno/metabolismo , Triglicéridos/metabolismo , Cromatografía de Afinidad , ADN Complementario , Concentración de Iones de Hidrógeno , Lipooxigenasa/química , Lipooxigenasa/genética , Proteínas Recombinantes/metabolismo , Glycine max/enzimología , Especificidad por Sustrato
8.
FEBS Lett ; 339(1-2): 189-94, 1994 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-8313972

RESUMEN

The complete amino acid sequence of an invertebrate calcium channel alpha 1-subunit from housefly (Musca domestica) larvae (designated Mdl alpha 1) has been deduced by cDNA cloning and sequence analysis. Mdl alpha 1 shares higher percent sequence identity with 1,4-dihydropyridine (DHP)-sensitive L-type than with DHP-insensitive calcium channels. As shown by whole mount in situ hybridization and immunostaining Mdl alpha 1 is predominantly expressed in the larval body wall musculature.


Asunto(s)
Canales de Calcio/genética , Clonación Molecular , Moscas Domésticas/química , Secuencia de Aminoácidos , Animales , ADN Complementario/química , ADN Complementario/genética , Dihidropiridinas/farmacología , Expresión Génica , Moscas Domésticas/genética , Hibridación in Situ , Larva/metabolismo , Datos de Secuencia Molecular , Músculos/metabolismo , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Análisis de Secuencia , Homología de Secuencia , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA